BlackRock’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,392
| Closed | -$10K | – | 5196 |
|
|
2019
Q4 | $10K | Hold |
11,392
| – | – | ﹤0.01% | 4742 |
|
|
2019
Q3 | $6K | Hold |
11,392
| – | – | ﹤0.01% | 4780 |
|
|
2019
Q2 | $6K | Hold |
11,392
| – | – | ﹤0.01% | 4821 |
|
|
2019
Q1 | $5K | Hold |
11,392
| – | – | ﹤0.01% | 4758 |
|
|
2018
Q4 | $5K | Hold |
11,392
| – | – | ﹤0.01% | 4754 |
|
|
2018
Q3 | $6K | Sell |
11,392
-84
| -0.7% | -$45 | ﹤0.01% | 4796 |
|
|
2018
Q2 | $6K | Hold |
11,476
| – | – | ﹤0.01% | 4813 |
|
|
2018
Q1 | $5K | Hold |
11,476
| – | – | ﹤0.01% | 4737 |
|
|
2017
Q4 | $4K | Hold |
11,476
| – | – | ﹤0.01% | 4756 |
|
|
2017
Q3 | $4K | Hold |
11,476
| – | – | ﹤0.01% | 4788 |
|
|
2017
Q2 | $4K | Hold |
11,476
| – | – | ﹤0.01% | 4846 |
|
|
2017
Q1 | $5K | Buy |
11,476
+84
| +0.7% | +$37 | ﹤0.01% | 4802 |
|
|
2016
Q4 | $4K | Hold |
11,392
| – | – | ﹤0.01% | 3568 |
|
|
2016
Q3 | $3K | Hold |
11,392
| – | – | ﹤0.01% | 3594 |
|
|
2016
Q2 | $3K | Hold |
11,392
| – | – | ﹤0.01% | 3627 |
|
|
2016
Q1 | $1K | Hold |
11,392
| – | – | ﹤0.01% | 3634 |
|
|
2015
Q4 | $1K | Hold |
11,392
| – | – | ﹤0.01% | 3424 |
|
|
2015
Q3 | $2K | Hold |
11,392
| – | – | ﹤0.01% | 3183 |
|
|
2015
Q2 | $8K | Hold |
11,392
| – | – | ﹤0.01% | 2967 |
|
|
2015
Q1 | $8K | Hold |
11,392
| – | – | ﹤0.01% | 2899 |
|
|
2014
Q4 | $9K | Hold |
11,392
| – | – | ﹤0.01% | 2865 |
|
|
2014
Q3 | $5K | Hold |
11,392
| – | – | ﹤0.01% | 3117 |
|
|
2014
Q2 | $6K | Hold |
11,392
| – | – | ﹤0.01% | 3111 |
|
|
2014
Q1 | $4K | Hold |
11,392
| – | – | ﹤0.01% | 3108 |
|
|
2013
Q4 | $4K | Hold |
11,392
| – | – | ﹤0.01% | 3113 |
|
|
2013
Q3 | $23K | Sell |
11,392
-1,190,085
| -99% | -$2.27M | ﹤0.01% | 2221 |
|
|
2013
Q2 | $2.28M | Buy |
+1,201,477
| New | +$2.11M | ﹤0.01% | 912 |
|
BlackRock's GCVRZ Position: Q1 2020 in Review
BlackRock sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 11,392 shares — an estimated $10K sold.
BlackRock first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $2.28M in Q2 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- BlackRock reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- BlackRock sold 11,392 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $10K.
- BlackRock first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- BlackRock's Sanofi Contingent Value Rights position peaked at $2.28M in Q2 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on BlackRock's 13F filing for Q1 2020, filed 1 May 2020.